Martifur MR 50mg Tablet contains Nitrofurantoin, a broad-spectrum antibacterial agent primarily indicated for the treatment and prevention of urinary tract infections (UTIs) caused by susceptible strains of bacteria. Nitrofurantoin exerts its bactericidal effect by inhibiting bacterial enzyme systems involved in carbohydrate metabolism, thereby disrupting bacterial cell wall synthesis and leading to cell death. Martifur MR is formulated as a modified-release tablet to provide sustained therapeutic plasma concentrations, enhancing efficacy and improving patient compliance by reducing dosing frequency. It is effective against common uropathogens including Escherichia coli, Staphylococcus saprophyticus, and Enterococci species. This medication is contraindicated in patients with significant renal impairment, as reduced renal function may lead to inadequate urinary drug concentrations and increased risk of toxicity. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and loss of appetite, while rare but serious side effects may involve pulmonary reactions, hepatotoxicity, and peripheral neuropathy. Martifur MR should be administered with food to improve absorption and minimize gastrointestinal discomfort. Clinical monitoring of renal function and symptom resolution is recommended during therapy. This medication should be used under medical supervision, adhering strictly to prescribed dosages to ensure optimal therapeutic outcomes and minimize resistance development.